Kohjin Bio CoTSE:177A -0.90%18 Piotroski F-Score is 4 as of Jul. 01, 2026, which is 20% below its 10-year median of 5.00. GuruFocus rates TSE:177A with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 1,337 Biotechnology companies, Kohjin Bio Co ranks better than 74.2% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Kohjin Bio Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for Kohjin Bio Co's Piotroski F-Score or its related term are showing as below:
TSE:177A'
s Piotroski F-Score Range Over the Past 10 Years
Min: 4 Med: 5 Max: 8
Current: 4
During the past 5 years, the highest Piotroski F-Score of Kohjin Bio Co was 8. The lowest was 4. And the median was 5.
Kohjin Bio Co (TSE:177A) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Kohjin Bio Co Piotroski F-Score Related Terms
Kohjin Bio Co Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Kohjin Bio Co's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:177A vs VRTX, REGN, ALNY: Piotroski F-Score Comparison
For the Biotechnology subindustry, Kohjin Bio Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kohjin Bio Co Piotroski F-Score vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kohjin Bio Co's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Kohjin Bio Co's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Kohjin Bio Co's current Net Income (TTM) was 251.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Kohjin Bio Co's return on assets of this year was 0.02768598. Kohjin Bio Co's return on assets of last year was 0.12061317.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Kohjin Bio Co's gearing of this year was 0.05427854. Kohjin Bio Co's gearing of last year was 0.08754577.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Kohjin Bio Co's current ratio of this year was 1.80143079. Kohjin Bio Co's current ratio of last year was 2.03713178.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Kohjin Bio Co's number of shares in issue this year was 5.112. Kohjin Bio Co's number of shares in issue last year was 5.044.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Kohjin Bio Co's gross margin of this year was 0.37603191. Kohjin Bio Co's gross margin of last year was 0.45445747.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Kohjin Bio Co's asset turnover of this year was 0.54474653. Kohjin Bio Co's asset turnover of last year was 0.79010967.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
0
+
1
+
1
+
0
+
0
+
0
+
0
=
4
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Kohjin Bio Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.
Kohjin Bio Co (TSE:177A) has a Piotroski F-Score of 4 as of Jul. 01, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Kohjin Bio Co and its competitors. This is 20% below median its historical median of 5.00. Over the past decade, Kohjin Bio Co's Piotroski F-Score has ranged from 4.00 to 8.00. According to the industry distribution chart, Kohjin Bio Co ranks #345 out of 1337 companies in the Biotechnology industry, placing it in the top 25.8%.
Is Kohjin Bio Co's Piotroski F-Score too high?
Kohjin Bio Co's current Piotroski F-Score of 4 is 20% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 8.00. The Biotechnology industry median Piotroski F-Score is 3.00. Kohjin Bio Co's value of 4 is 33.3% above this industry median. Based on the distribution chart, Kohjin Bio Co ranks #345 out of 1337 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Kohjin Bio Co has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Kohjin Bio Co's Piotroski F-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kohjin Bio Co ranks #345 out of 1337 companies for Piotroski F-Score. This puts Kohjin Bio Co in the upper half of its industry. The industry median Piotroski F-Score is 3.00. Kohjin Bio Co's value of 4 is 33.3% above this benchmark. Historically, Kohjin Bio Co's own Piotroski F-Score has ranged from 4.00 to 8.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 3.00, Kohjin Bio Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Biotechnology company?
The median Piotroski F-Score among Biotechnology companies is 3.00, based on 1,337 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kohjin Bio Co's current Piotroski F-Score of 4 is 33.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Kohjin Bio Co and its competitors. For the Biotechnology industry, the median Piotroski F-Score is 3.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kohjin Bio Co's current Piotroski F-Score is 4, which is 20% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kohjin Bio Co stock overvalued right now?
Kohjin Bio Co (TSE:177A) has a current Piotroski F-Score of 4. The current Piotroski F-Score is 4, which is 20% below median its 10-year median of 5.00 and 33.3% above the Biotechnology industry median of 3.00. Kohjin Bio Co's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Kohjin Bio Co (TSE:177A), the current Piotroski F-Score is 4 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
18GF Score
Get the complete analysis for TSE:177A
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:177A has been successfully added to your 